Viatris, Inc. (VTRS)
18.00
-0.48
(-2.60%)
USD |
NASDAQ |
Oct 23, 16:00
18.12
+0.12
(+0.67%)
After-Hours: 20:00
Viatris Market Cap : 20.79B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 20.79B |
| October 22, 2026 | 21.35B |
| October 21, 2026 | 21.31B |
| October 20, 2026 | 21.55B |
| October 19, 2026 | 21.09B |
| October 16, 2026 | 21.55B |
| October 15, 2026 | 21.05B |
| October 14, 2026 | 20.15B |
| October 13, 2026 | 19.93B |
| October 12, 2026 | 20.26B |
| October 09, 2026 | 20.38B |
| October 08, 2026 | 20.15B |
| October 07, 2026 | 20.21B |
| October 06, 2026 | 20.26B |
| October 05, 2026 | 20.36B |
| October 02, 2026 | 20.33B |
| October 01, 2026 | 20.17B |
| September 30, 2026 | 20.47B |
| September 29, 2026 | 20.93B |
| September 28, 2026 | 21.11B |
| September 25, 2026 | 20.60B |
| September 24, 2026 | 20.12B |
| September 23, 2026 | 19.78B |
| September 22, 2026 | 19.85B |
| September 21, 2026 | 19.75B |
| Date | Value |
|---|---|
| September 18, 2026 | 19.58B |
| September 17, 2026 | 19.79B |
| September 16, 2026 | 19.66B |
| September 15, 2026 | 19.23B |
| September 14, 2026 | 19.25B |
| September 11, 2026 | 19.07B |
| September 10, 2026 | 18.92B |
| September 09, 2026 | 19.06B |
| September 08, 2026 | 19.19B |
| September 04, 2026 | 19.50B |
| September 03, 2026 | 19.57B |
| September 02, 2026 | 19.74B |
| September 01, 2026 | 19.21B |
| August 31, 2026 | 19.07B |
| August 28, 2026 | 18.88B |
| August 27, 2026 | 19.51B |
| August 26, 2026 | 19.47B |
| August 25, 2026 | 19.32B |
| August 24, 2026 | 19.11B |
| August 21, 2026 | 18.85B |
| August 20, 2026 | 18.62B |
| August 19, 2026 | 18.77B |
| August 18, 2026 | 18.68B |
| August 17, 2026 | 18.75B |
| August 14, 2026 | 18.75B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pacira Biosciences, Inc. | 1.450B |
| Eli Lilly & Co. | 1.199T |
| Merck & Co., Inc. | 358.62B |
| Pfizer Inc. | 171.14B |
| Harrow, Inc. | 1.066B |
Market Cap Related Metrics
| PS Ratio | 1.420 |
| Price to Book Value | 1.458 |
| Price to Free Cash Flow | 11.60 |
| Price | 18.00 |
| Earnings Yield | -1.98% |
| Operating PE Ratio | 14.66 |
| Normalized PE Ratio | 35.66 |